Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Facing the fear: a new program aims to ease anxiety in advanced cancer

NCT ID NCT03776253

Symptom relief Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study tests a psychosocial program called Conquer Fear Support (CFS) for people with stage III or IV lung or gynecologic cancer who are experiencing fear of cancer progression. The program includes psychoeducation, attention training, worry management, and detached mindfulness techniques. The goal is to see if it is feasible and acceptable, and whether it can help reduce worries, fears, and uncertainty. Participants will attend seven sessions and practice skills at home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Conquer Fear Support (CFS) – a psychosocial intervention involving psychoeducation, attention training, worry management, and detached mindfulness
What this could lead to
If effective, this program could offer a practical way to reduce fear and uncertainty for people living with advanced cancer, improving their emotional well-being.
What could go wrong
This is a small pilot study, so results may not apply broadly. The intervention requires time and practice, and not everyone may find it helpful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

39 people

The number who actually took part.

Started

Nov 2018

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with gynecologic (GYN) and lung cancer will be recruited * Stage III or IV disease * At least 3 months from initial diagnosis * Receiving disease-focused treatment or active surveillance mode * A score of ≥ 34 on the Fear of Progression Questionnaire-Short Form (SF) or ≥ 24 on the Impact of Event Scale-Revised * All subjects must have the ability to understand and the willingness to sign a written informed consent Exclusion Criteria: * Current severe depression or psychosis; significant cognitive impairment * Patients enrolled in hospice care or who opt to receive no further disease-focused treatment * Patients who are currently receiving ongoing psychiatric treatment * Non-English speaking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced lung carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer lung cancer lung carcinoma lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced lung carcinoma Malignant female reproductive system neoplasm Stage III lung cancer ajcc V8 Stage IIIA lung cancer ajcc V8 Stage IIIB lung cancer ajcc V8 Stage IIIC lung cancer ajcc V8 Stage IV lung cancer ajcc V8

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.